PARIS--(BUSINESS WIRE)--ScreenCell has entered into a collaborative study with the Jefferson Breast Care Center at the Sidney Kimmel Cancer Center of Thomas Jefferson University in Philadelphia, to evaluate the effectiveness of ScreenCell’s proprietary devices and protocols for enrichment of Circulating Tumor Cells (CTCs) from peripheral blood. ScreenCell technology separates CTCs from blood components by differential size.
Help employers find you! Check out all the jobs and post your resume.
